At the core of this study is the mitochondrion, often characterized as the powerhouse of the cell. Its multifunctional role extends beyond energy production; it is integral to regulating cellular respiration, apoptosis, and metabolic homeostasis. Researchers have long sought to augment mitochondrial function, particularly in the context of various diseases characterized by mitochondrial dysfunction. Malakauskaitė et al. have propelled this inquiry forward by investigating how precisely timed electric pulses can modulate mitochondrial properties.

The focus on ultra-fast nanosecond electric pulses is particularly noteworthy. Traditional electroporation techniques involve longer pulses that cause extensive disruptions to cellular membranes. In contrast, nanosecond pulses are remarkable for their ability to induce transient permeability changes without causing permanent damage to the cellular architecture. This unique feature underlines the potential for therapeutic applications where controlled electric fields can make subtle yet profound alterations to cellular behavior.

In this study, the researchers meticulously measured the transmembrane potential of mitochondria after exposing cells to nanosecond electric pulses. This parameter is critical as it reflects the driving force for ATP synthesis, which is imperative for cellular energy. The findings suggest that the application of these pulses resulted in a significant increase in mitochondrial membrane potential, enhancing ATP production in a variety of cell types. The implications of this enhancement could be vast, especially in regenerative medicine and in treatments targeting metabolic disorders.

To further elucidate the underlying mechanisms of these effects, the researchers examined the oxidative state of cells post-treatment. Understanding the balance between oxidative stress and antioxidant defenses is vital in elucidating how cells respond to electrical stimuli. The results of the study indicated an intricate interplay between electric pulse application and the modulation of reactive oxygen species (ROS) production. This relationship is crucial, as ROS are not merely byproducts of metabolism; they serve as signaling molecules that can initiate cellular responses leading to survival or death.

Additionally, the research delves into the potential implications for cancer therapy. Tumor cells often exploit dysfunctional mitochondrial pathways, leading to altered energy metabolism that supports rapid proliferation. By harnessing the effects of nanosecond electric pulses, there may be a novel approach to reprogram these dysfunctional metabolic pathways, ultimately enhancing the efficacy of existing treatment modalities or paving the way for new interventions.

The concept of using electric fields to influence cellular properties is not entirely new, but the precision and rapidity of the pulses explored in this study present an exciting frontier. The researchers highlight the novelty of their methodologies, which allow for acute experiments that minimize cellular adaptation or long-term changes that could skew results. This precision positions nanosecond pulse technology as an invaluable tool in understanding cellular responses to bioelectricity.

Furthermore, the researchers addressed potential applications beyond cancer therapy. For instance, the ability to modulate mitochondrial function may also extend to neurodegenerative diseases where cell death and energy depletion are prominent features. By optimizing electric pulse parameters, the potential exists to stimulate mitochondrial repair mechanisms or induce protective responses in vulnerable cell types.

The significance of these findings cannot be overstated. By showcasing that the application of ultra-fast electric pulses can improve mitochondrial function, the study paves the way for multidisciplinary collaborations. Researchers from fields such as materials science, bioengineering, and clinical medicine may converge to explore and manipulate these findings, leading to innovative therapeutic strategies that could address an array of diseases at the cellular level.

Ethically, the study addresses important considerations regarding the translation of laboratory findings into clinical settings. The potential for electric field applications in human treatments raises questions about safety, efficacy, and patient consent. The authors propose that thorough preclinical studies and a strong regulatory framework will be essential for the responsible integration of such methodologies into healthcare settings.

In conclusion, the exploration conducted by Malakauskaitė et al. serves as a significant milestone in the realm of cellular bioelectricity. The implications of their work resonate not only within the confines of specialized research but also in broader medical and therapeutic contexts. This groundbreaking research illuminates pathways to harness electric pulses for advanced biomedical applications, offering hope for innovative treatments for various diseases marked by cellular dysfunction.

The energy revolution on a cellular level identified by this research raises a plethora of questions and invites further investigation into the myriad ways bioelectric phenomena can be harnessed. As the field progresses, one can anticipate the emergence of even more unconventional and effective strategies that combine biological understanding with technological innovation.

By continuing to develop and optimize these nanosecond electric pulses, researchers may unlock novel avenues for cell therapy, organ regeneration, and other transformative healthcare solutions that could change the landscape of medicine as we know it.

Through this research, we stand on the brink of a new era where the language of biology may be spoken in terms of electric frequencies, opening doors to therapeutic interventions previously relegated to the realm of science fiction.

Subject of Research: Effects of ultra-fast nanosecond electric pulses on mitochondrial transmembrane potential and oxidation.

Article Title: Effects of ultra-fast nanosecond electric pulses on mitochondria transmembrane potential and oxidation.

Article References: Malakauskaitė, P., Želvys, A., Mickevičiūtė, E. et al. Effects of ultra-fast nanosecond electric pulses on mitochondria transmembrane potential and oxidation.
Sci Rep 15, 39778 (2025). https://doi.org/10.1038/s41598-025-23453-6

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41598-025-23453-6

Keywords: Ultra-fast electric pulses, mitochondria, transmembrane potential, oxidative stress, energy metabolism, nanosecond pulses.

The Pew Scholars program, established over four decades ago, consistently fosters the growth of talented young scientists who approach intricate biomedical challenges with novel methodologies and interdisciplinary perspectives. Donna Frisby-Greenwood, Pew’s senior vice president for Philadelphia and scientific advancement, emphasized the enduring legacy of this award: “For 40 years, Pew has supported young, talented researchers as they take creative approaches to solving big scientific questions. This new class continues that legacy, and we look forward to seeing where their discoveries lead.”

Dr. Burton’s research uniquely positions him at the intersection of environmental biology, developmental programming, and microbial ecology. His focus lies in understanding how complex environmental factors, such as stress and microbial exposure, modulate human health outcomes across generations. This pioneering approach draws heavily on the developmental origins of health and disease (DOHaD) hypothesis, which posits that environmental influences during critical windows of development—particularly prenatal and early postnatal periods—can have lasting effects on physiology, disease susceptibility, and metabolic function.

Central to Burton’s laboratory is the investigation of how ambient environmental microbes may exert epigenetic and immunological effects on offspring, potentially altering their vulnerability to metabolic disorders. This work involves sophisticated genomic and metabolomic profiling techniques to unravel the molecular mechanisms that mediate host-microbe interactions in both maternal and fetal tissues. His research also extends to the biochemical characterization of microbial byproducts, illuminating how symbiotic relationships with environmental bacteria can influence metabolic signaling pathways.

A particularly innovative facet of Burton’s research is his exploration of soil-derived bacteria as a source of novel therapeutic agents, specifically for Type 2 diabetes. The rationale for this approach is grounded in the historic success of microbe-derived medicines, from antibiotics to immunosuppressive drugs. By applying advanced bioinformatics and chemical biology tools, his team screens microbial metabolites for bioactivity that could modulate insulin sensitivity, glucose metabolism, or inflammatory responses characteristic of diabetes pathology. Such work not only holds translational potential but also exemplifies the convergence of environmental microbiology and metabolic disease research.

Burton’s academic journey reflects a trajectory dedicated to excellence and interdisciplinary inquiry. Having earned his Ph.D. from the Massachusetts Institute of Technology and completed a prestigious Next Generation Fellowship at the University of Cambridge’s Centre for Trophoblast Research, he brought a wealth of knowledge to VAI upon joining as an assistant professor in the Department of Metabolism and Nutritional Programming in 2021. His work embodies the philosophy that understanding metabolism requires integrating nutritional science, molecular biology, and environmental exposures.

The scientific community stands to benefit greatly from the fresh perspectives Burton contributes. His approach aligns with a broader shift in biomedical research that recognizes the microbiome and environmental context as critical determinants of health. Incorporating techniques like high-throughput sequencing, metabolomics, and advanced computational modeling, his investigations aim to delineate the complex networks linking environment, microbial ecology, host development, and chronic disease.

This four-year Pew award will provide Burton with crucial resources to expand the scope and depth of his investigations. It will also connect him to a vibrant network of scholars who, over the past 35 years, have driven transformative advances in cancer biology, neuroscience, immunology, and beyond. The grant encourages recipients to pursue high-risk, high-reward research that challenges existing paradigms and accelerates biomedical innovation.

Beyond the laboratory, Burton expresses a profound appreciation for the opportunity to collaborate with fellow Pew Scholars. “I’m grateful to The Pew Charitable Trusts for the opportunity to be part of such an excellent community of scientists,” he said. “Pew Scholars pursue bold, innovative ideas to improve health, and I’m thrilled to join them.” This sentiment highlights the crucial role of scientific networks in fostering interdisciplinary dialogue and catalyzing breakthroughs.

The Van Andel Institute itself is recognized as a hub of scientific discovery, committed to unearthing the biological mechanisms behind cancer, Parkinson’s disease, and other major health challenges. VAI emphasizes translational research with the goal of developing novel prevention and treatment modalities. Burton’s affiliation with this forward-thinking institution underscores the alignment between his research vision and the Institute’s mission to improve health outcomes through molecular and cellular biology.

As interest grows in how environmental factors shape metabolic diseases and developmental health, Dr. Burton’s research stands at the forefront of an emerging field with broad public health implications. His efforts not only promise advances in understanding and treating Type 2 diabetes but also foster a nuanced appreciation for the complex interplay between humans and their microbial environments.

The recognition by The Pew Charitable Trusts marks not only a personal achievement for Burton but also highlights the increasing importance of research on environmental contributions to human health. As scientific inquiry continues to unravel these intricate relationships, it is researchers like Burton who pave the way for innovative therapies and preventive strategies that transcend traditional biomedical boundaries.

Subject of Research: Developmental programming, environmental microbiology, metabolic health, Type 2 diabetes therapies
Article Title: Van Andel Institute’s Dr. Nick Burton Named 2025 Pew Scholar in Biomedical Sciences
News Publication Date: August 12, 2025
Web References:

• https://www.pew.org/en/about/news-room/press-releases-and-statements/2025/08/12/pew-awards-22-researchers-biomedical-science-grants
• http://burtonlab.vai.org/
• https://www.vai.org/article/could-backyard-bacteria-and-hungry-worms-help-solve-a-central-problem-in-type-2-diabetes/
• http://www.vai.org/
  Image Credits: Courtesy of Van Andel Institute
  Keywords: Metabolic health, Environmental microbiology, Developmental programming, Type 2 diabetes, Biomedical research, Microbial metabolites

Since its inception in 1985, the Pew Scholars Program has been a catalyst for innovation, underwriting the creative efforts of researchers at a critical stage in their careers—junior faculty embarking on independent labs and novel projects. The 2025 class forms the 40th cohort of scholars, an elite network now exceeding 1,000 scientists whose collective work spans a remarkable breadth of biomedical disciplines. These scholars gain not only financial support but also access to a vibrant community that encourages multidisciplinary collaboration and idea exchange, vital components in accelerating scientific breakthroughs.

The current group emerges from a competitive pool of 209 nominees, each put forward by leading U.S. academic institutions. Their research portfolios showcase the use of cutting-edge methodologies, including advanced molecular biology, synthetic biology, computational modeling, and state-of-the-art imaging techniques. Their scientific inquiries cover a wide spectrum—from dissecting the complex interplay between the microbiome and host metabolism to unraveling the genetic blueprints shaping neural circuits and developmental processes in the brain.

Several scholars are delving into the intricate molecular interactions underlying infectious diseases. For example, one investigator from Harvard is pioneering studies into the mechanistic interfaces between human cells and emerging pathogens like coronaviruses and simian hemorrhagic fever viruses, using high-resolution structural biology tools to elucidate viral entry and immune evasion strategies. Such work has critical implications for pandemic preparedness and viral therapeutics.

Others focus on immune system dynamics and neural health, notably exploring how brain-resident immune cells contribute to neural development and behavioral outcomes, with an emphasis on sex-specific differences. These investigations employ sophisticated genetic and cellular assays, including single-cell transcriptomics and epigenetic profiling, aiming to untangle how immunity intersects with neurobiology across the lifespan.

A noteworthy cluster of scholars investigates metabolic reprogramming at the cellular and molecular levels. One Berkeley-based researcher is examining the spatial reorganization of subcellular architecture that enables cells to adapt their metabolic pathways—a study that could illuminate fundamental principles of cellular plasticity and identify new targets for metabolic diseases. Complementarily, another scientist at Van Andel Institute is probing the microbiome’s capacity to ameliorate metabolic disorders, decoding the molecular linguistics that allow commensal bacteria to regulate host physiology.

The spectrum of developmental biology is represented too, with research aimed at embryo resilience, maternal environmental impacts on development, and the maintenance of reproductive capacity over extended lifespans, such as in sea stars. These endeavors utilize innovative in vivo imaging, genome editing technologies like CRISPR, and artificial intelligence-enabled data analysis to uncover developmental trajectories and their modulation by extrinsic factors.

Adding to the diversity of cutting-edge science, one scholar is advancing synthetic biology approaches to engineer programmable cis-regulatory DNA elements. This pioneering work seeks to refine gene therapy techniques by controlling spatial and temporal gene expression, a critical step toward precision medicine applications with minimized off-target effects. Meanwhile, others are constructing novel RNA-based therapeutics, designing stable and controllable RNAs with enhanced therapeutic indices and delivery capabilities.

The program also highlights scientists leveraging virtual reality platforms to investigate spatial navigation and memory recall processes in the brain, illustrating how technological integration can revolutionize neuroscience research. Employing custom-designed virtual environments alongside electrophysiological monitoring, these efforts aim to decode neural circuit dynamics and cognitive function.

Furthermore, several scholars focus on health disparities and historical epidemiology, such as genetic and health impact studies related to the transatlantic African diaspora during the colonial period. Their interdisciplinary approaches combine population genomics, bioinformatics, and historical data analysis to elucidate how migratory patterns and sociocultural factors have shaped contemporary human health outcomes.

A meaningful subset of the 2025 Pew Scholars, supported by the Kathryn W. Davis Peace by Pieces Fund, concentrate on aging-related cerebral health challenges, investigating mechanisms of brain aging, neurodegeneration, and related pathologies. Through integrative methodologies encompassing molecular neuroscience, imaging, and behavioral assays, their work promises to yield insights into preserving cognitive function and combating neurological decline.

Together, this generation of scholars exemplifies the vitality and breadth of contemporary biomedical research. Their projects, employing sophisticated technological toolkits and theoretical frameworks, promise not only to advance basic science but also to lay the groundwork for novel medical interventions addressing a range of human diseases. The Pew Charitable Trusts’ sustained investment in these early-career investigators underscores a strategic vision: by empowering the next wave of scientific leaders, it propels the biomedical frontier toward a future of enhanced health and well-being worldwide.

Subject of Research: Biomedical sciences, including molecular biology, neuroscience, microbiome research, developmental biology, immunology, synthetic biology, metabolic disease mechanisms, viral pathogenesis, aging, and genetic epidemiology.

Article Title: Not provided

News Publication Date: Not provided

Web References: Not provided

References: Not provided

Image Credits: Not provided

Keywords: Biomedical research funding, Biochemistry, Cell biology, Developmental biology, Genetics, Immunology, Microbiology, Neuroscience, Plant sciences